drugset / Trial / NCT05509725

Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)

NCT05509725 ↗

Phase 4 Unknown 162 enrolled Lallemand Health Solutions
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of the study is to monitor safety and to evaluate the efficacy of a probiotic formulation on abdominal pain, abnormal defecation, comorbid mood disorders (anxiety and depression) as well as general quality of life in adults with IBS-D.

Timeline

Start
2022-08-11
Primary completion
2024-11
Completion
2024-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Probiotic formulation Unknown — —